[Letter to the Editor]Reply to: “Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?”
- J. Hepatol., Available online 25 May 2020 | https://doi.org/10.1016/j.jhep.2020.04.016